Repression of Id2 expression by Gfi-1 is required for B-cell and myeloid development

Blood

Volumn 116, Issue 7, 2010, Pages 1060-1069

  Li, Huajie ^a   Ji, Ming ^a   Klarmann, Kimberly D ^a   Keller, Jonathan R ^a  

^a SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INHIBITOR OF DIFFERENTIATION 2; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GFI 1; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; GFI1 PROTEIN, MOUSE; IDB2 PROTEIN, MOUSE; LUCIFERASE; MESSENGER RNA;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; MOUSE; MYELOID PROGENITOR CELL; NEUTROPHIL; NONHUMAN; PRE B LYMPHOCYTE; PRE T LYMPHOCYTE; PRIORITY JOURNAL; PROMOTER REGION; T LYMPHOCYTE; ANIMAL; ANTAGONISTS AND INHIBITORS; BONE MARROW CELL; CELL PROLIFERATION; CFU COUNTING; CHROMATIN IMMUNOPRECIPITATION; CYTOLOGY; ENZYME IMMUNOASSAY; FLOW CYTOMETRY; GEL MOBILITY SHIFT ASSAY; GENETIC TRANSFECTION; GENETICS; KNOCKOUT MOUSE; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; WESTERN BLOTTING;

ANIMALS; B-LYMPHOCYTES; BASE SEQUENCE; BLOTTING, WESTERN; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; COLONY-FORMING UNITS ASSAY; DNA-BINDING PROTEINS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FLOW CYTOMETRY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; IMMUNOENZYME TECHNIQUES; INHIBITOR OF DIFFERENTIATION PROTEIN 2; LUCIFERASES; MICE; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; MYELOID CELLS; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE HOMOLOGY, NUCLEIC ACID; T-LYMPHOCYTES; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 77956496727     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-11-255075     Document Type: Article

References (51)

1. Matthias P, Rolink AG. Transcriptional networks in developing and mature B cells. Nat Rev Immunol. 2005;5(6):497-508.
2. Laiosa CV, Stadtfeld M, Graf T. Determinants of lymphoid-myeloid lineage diversification. Ann Rev Immunol. 2006;24:705-738.
3. Laslo P, Spooner CJ, Warmflash A, et al. Multilineage transcriptional priming and determination of alternate hematopoietic cell fates. Cell. 2006;126(4):755-766. (Pubitemid 44233633)
4. Laslo P, Pongubala JMR, Lancki DW, Singh H. Gene regulatory networks directing myeloid and lymphoid cell fates within the immune system. Semin Immunol. 2008;20(4):228-235.
5. Gilks CB, Bear SE, Grimes HL, Tsichlis PN. Progression of interleukin-2 (Il-2)-dependent rat T-cell lymphoma lines to IL-2-independent growth following activation of a gene (Gfi-1) encoding a novel zinc finger protein. Mol Cell Biol. 1993;13(3):1759-1768.
6. Zweidler-McKay PA, Grimes HL, Flubacher MM, Tsichlis PN. Gfi-1 encodes a nuclear zinc finger protein that binds DNA and functions as a transcriptional repressor. Mol Cell Biol. 1996;16(8):4024-4034.
7. Yücel R, Karsunky H, Klein-Hitpass L, Moroy T. The transcriptional repressor Gfi1 affects development of early, uncommitted c-Kit+ T cell progenitors and CD4/CD8 lineage decision in the thymus. J Exp Med. 2003;197(7):831-844. (Pubitemid 36437861)
8. Rathinam C, Klein C. Transcriptional repressor Gfi1 integrates cytokine-receptor signals controlling B-cell differentiation. PLoS ONE. 2007;2(3):e306.
9. Karsunky H, Zeng H, Schmidt T, et al. Inflammatory reactions and severe neutropenia in mice lacking the transcriptional repressor Gfi1. Nat Genet. 2002;30(3):295-300.
10. Hock H, Hamblen MJ, Rooke HM, S et al. Intrinsic requirement for zinc finger transcription factor Gfi-1 in neutrophil differentiation. Immunity. 2003;18(1):109-120. (Pubitemid 36120692)
11. Person RE, Li FQ, Duan ZJ, et al. Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2. Nat Genet. 2003;34(3):308-312.
12. Zeng H, Yucel R, Kosan C, Klein-Hitpass L, Moroy T. Transcription factor Gfi1 regulates self-renewal and engraftment of hematopoietic stem cells. EMBO J. 2004;23(20):4116-4125. (Pubitemid 39472432)
13. Hock H, Hamblen MJ, Rooke HM, et al. Gfi-1 restricts proliferation and preserves functional integrity of haematopoietic stem cells. Nature. 2004;431(7011):1002-1007. (Pubitemid 39434423)
14. Norton JD, Deed RW, Craggs G, Sablitzky F. Id helix-loop-helix proteins in cell growth and differentiation. Trends Cell Biol. 1998;8(2):58-65. (Pubitemid 28056812)
15. Israel MA, Hernandez MC, Florio M, et al. Id gene expression as a key mediator of tumor cell biology. Cancer Res. 1999;59(7 suppl):1726s-1730s.
16. Norton JD. ID helix-loop-helix proteins in cell growth, differentiation and tumorigenesis. J Cell Sci. 2000;113(Pt 22):3897-3905.
17. Sun XH, Copeland NG, Jenkins NA, Baltimore D. Id proteins Id1 and Id2 selectively inhibit DNA binding by one class of helix-loop-helix proteins. Mol Cell Biol. 1991;11(11):5603-5611.
18. Iavarone A, Garg P, Lasorella A, Hsu J, Israel MA. The helix-loop-helix protein Id-2 enhances cell proliferation and binds to the retinoblastoma protein. Genes Dev. 1994;8(11):1270-1284. (Pubitemid 24181319)
19. VoronovaAF, Lee F. The E2Aand tal-1 helix-loop-helix proteins associate in vivo and are modulated by Id proteins during interleukin 6-induced myeloid differentiation. Proc Natl Acad Sci U S A. 1994;91(13):5952-5956.
20. Yates PR, Atherton GT, Deed RW, Norton JD, Sharrocks AD. Id helix-loop-helix proteins inhibit nucleoprotein complex formation by the TCF ETS-domain transcription factors. EMBO J. 1999;18(4):968-976.
21. Roberts EC, Deed RW, Inoue T, Norton JD, Sharrocks AD. Id helix-loop-helix proteins antagonize Pax transcription factor activity by inhibiting DNA binding. Mol Cell Biol. 2001;21(2):524-533. (Pubitemid 32037372)
22. Sun XH. Constitutive expression of the Id1 gene impairs mouse B cell development. Cell. 1994;79(5):893-900. (Pubitemid 24371979)
23. Kim D, Peng XC, Sun XH. Massive apoptosis of thymocytes in T-cell-deficient Id1 transgenic mice. Mol Cell Biol. 1999;19(12):8240-8253. (Pubitemid 30414018)
24. Morrow MA, Mayer EW, Perez CA, Adlam M, Siu G. Overexpression of the Helix-Loop-Helix protein Id2 blocks T cell development at multiple stages. Mol Immunol. 1999;36(8):491-503. (Pubitemid 29386148)
25. Kee BL, Rivera RR, Murre C. Id3 inhibits B lymphocyte progenitor growth and survival in response to TGF-beta. Nat Immunol. 2001;2(3):242-247. (Pubitemid 33706001)
26. Leeanansaksiri W, Wang H, Gooya JM, et al. IL-3 induces inhibitor of DNA-binding protein-1 in hemopoietic progenitor cells and promotes myeloid cell development. J Immunol. 2005;174(11):7014-7021. (Pubitemid 40705666)
27. Ji M, Li HJ, Suh HC, Klarmann KD, Yokota Y, Keller JR. Id2 intrinsically regulates lymphoid and erythroid development via interaction with different target proteins. Blood. 2008;112(4):1068-1077.
28. Suh HC, Leeanansaksiri W, Ji M, et al. Id1 immortalizes hematopoietic progenitors in vitro and promotes a myeloproliferative disease in vivo. Oncogene. 2008;27(42):5612-5623.
29. Yokota Y, Mansouri A, Mori S, et al. Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2. Nature. 1999;397(6721):702-706. (Pubitemid 29108390)
30. National Research Council. Guide for Care and Use of Laboratory Animals. 7th ed. 1996; National Academy Press; Washington, DC.
31. Ihle JN. Biochemical and biologic properties of interleukin-3 - a lymphokine mediating the differentiation of a lineage of cells that includes prothymocytes and mastlike cells. Contemp Topics Mol Immunol. 1985;10:93-119.
32. Tsai S, Bartelmez S, Sitnicka E, Collins S. Lymphohematopoietic progenitors immortalized by a retroviral vector harboring a dominant-negative retinoic acid receptor can recapitulate lymphoid, myeloid, and erythroid development. Genes Dev. 1994;8(23):2831-2841.
33. Rolink A, tenBoekel E, Melchers F, Fearon DT, Krop I, Andersson J. A subpopulation of B220(+) cells in murine bone marrow does not express CD19 and contains natural killer cell progenitors. J Exp Med. 1996;183(1):187-194.
34. Semerad CL, Mercer EM, Inlay MA, Weissman IL, Murre C. E2A proteins maintain the hematopoietic stem cell pool and promote the maturation of myelolymphoid and myeloerythroid progenitors. Proc Natl Acad Sci U S A. 2009;106(6):1930-1935.
35. Dias S, Mansson R, Gurbuxani S, Sigvardsson M, Kee BL. E2A proteins promote development of lymphoid-primed multipotent progenitors. Immunity. 2008;29(2):217-227.
36. Yang Q, Kardava L, Leger AS, et al. E47 controls the developmental integrity and cell cycle quiescence of multipotential hematopoietic progenitors. J Immunol. 2008;181(9):5885-5894.
37. Iavarone A, King ER, Dai XM, Leone G, Stanley ER, Lasorella A. Retinoblastoma promotes definitive erythropoiesis by repressing Id2 in fetal liver macrophages. Nature. 2004;432(7020):1040-1045. (Pubitemid 40052236)
38. Gonda H, Sugai M, Nambu Y, et al. The balance between Pax5 and Id2 activities is the key to AID gene expression. J Exp Med. 2003;198(9):1427-1437. (Pubitemid 37392487)
39. Pongubala JMR, Northrup DL, Lancki DW, et al. Transcription factor EBF restricts alternative lineage options and promotes B cell fate commitment independently of Pax5. Nat Immunol. 2008;9(2):203-215.
40. Thal MA, Carvalho TL, He T, et al. Ebf1-mediated down-regulation of Id2 and Id3 is essential for specification of the B cell lineage. Proc Natl Acad Sci U S A. 2009;106(2):552-557.
41. Dahl R, Iyer SR, Owens KS, Cuylear DD, Simon MC. The transcriptional repressor GFI-1 antagonizes PU.1 activity through protein-protein interaction. J Biol Chem. 2007;282(9):6473-6483. (Pubitemid 47100818)
42. Zarebski A, Velu CS, Baktula AM, et al. Mutations in growth factor independent-1 associated with human neutropenia mock murine granulopoiesis through colony stimulating factor-1. Immunity. 2008;28(3):370-380.
43. Horman SR, Velu CS, Chaubey A, et al. Gfi1 integrates progenitor versus granulocytic transcriptional programming. Blood. 2009;113(22):5466-5475.
44. Cochrane SW, Zhao Y, Welner RS, Sun XH. Balance between Id and E proteins regulates myeloid-versus-lymphoid lineage decisions. Blood. 2009;113(5):1016-1026.
45. Rosenbauer F, Wagner K, Kutok JL, et al. Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU. 1. Nat Genet. 2004;36(6):624-630. (Pubitemid 38715991)
46. Dakic A, Metcalf D, Di Rago L, Mifsud S, Wu L, Nutt SL. PU.1 regulates the commitment of adult hematopoietic progenitors and restricts granulopoiesis. J Exp Med. 2005;201(9):1487-1502. (Pubitemid 40664092)
47. Dakic A, Metcalf D, Di Rago L, Mifsud S, Wu L, Nutt SL. Excess granulopoiesis and subsequent acute myeloid leukemia induced by complete loss of PU. 1 in adult mice. Tissue Antigens. 2005;66(5):388-389.
48. Metcalf D, Dakic A, Mifsud S, Di RL, Wu L, Nutt S. Inactivation of PU.1 in adult mice leads to the development of myeloid leukemia. Proc Natl Acad Sci U S A. 2006;103(5):1486-1491. (Pubitemid 43191192)
49. Shapiro LH. Myb and Ets proteins cooperate to transactivate an early myeloid gene. J Biol Chem. 1995;270(15):8763-8771.
50. Ueda-Hayakawa I, Mahlios J, Zhuang Y. Id3 restricts the developmental potential of gamma delta lineage during thymopoiesis. J Immunol. 2009;182(9):5306-5316.
51. Suh HC, Ji M, Gooya J, Lee M, Klarmann KD, Keller JR. Cell-nonautonomous function of Id1 in the hematopoietic progenitor cell niche. Blood. 2009;114(6):1186-1195.